nach oben

The European Journal of Health Economics

Erschienen in:

18.04.2018 | Editorial

What should we know about the person behind a TTO?

verfasst von: Floortje van Nooten, Jan Busschbach, Michel van Agthoven, Job van Exel, Werner Brouwer

Erschienen in: The European Journal of Health Economics | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Excerpt

The time trade-off (TTO) method is widely used to obtain quality of life scores for health states, but its validity is not uncontested, for instance because TTO values for similar health states can differ substantially between studies [1]. This could be caused by differences between studies in how the procedure is applied, but could also relate to differences in study samples. …

Arnesen, T., Trommald, M.: Are QALYs based on time trade-off comparable?—a systematic review of TTO methodologies. Health Econ. 14(1), 39–53 (2005)CrossRef

Attema, A.E., Brouwer, W.B.F.: The value of correcting values: influence and importance of correcting TTO scores for time preference. Value Health 13(8), 879–884 (2010)CrossRef

Zarate, V., Kind, P., Chuang, L.: Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans. Value Health 11(7), 1170–1177 (2008)CrossRef

Woloshin, S., Schwartz, L.M., Moncur, M., Gabriel, S., Tosteson, A.N.: Assessing values for health: numeracy matters. Med. Decis. Mak. 21(5), 382–390 (2001)CrossRef

Devlin, N.J., Tsuchiya, A., Buckingham, K., Tilling, C.: A uniform time trade off method for states better and worse than dead: feasibility study of the ‘lead time’ approach. Health Econ. 20(3), 348–361 (2011)CrossRef

Torrance, G.W.: Toward a utility theory foundation for health status index models. Health Serv. Res. 11(4), 349–369 (1976)PubMedPubMedCentral

Bleichrodt, H.: A new explanation for the difference between time trade-off utilities and standard gamble utilities. Health Econ. 11(5), 447–456 (2002)CrossRef

van Osch, S.M., Wakker, P.P., van den Hout, W.B., Stiggelbout, A.M.: Correcting biases in standard gamble and time tradeoff utilities. Med. Decis. Mak. 24(5), 511–517 (2004)CrossRef

Doctor, J.N., Bleichrodt, H., Lin, H.J.: Health utility bias: a systematic review and meta-analytic evaluation. Med. Decis. Mak. 30(1), 58–67 (2010)CrossRef

10.

de Wit, G.A., Busschbach, J.J.V., de Charro, F.T.: Sensitivity and perspective in the valuation of health status: whose values count? Health Econ. 9, 109–126 (2000)CrossRef

11.

Versteegh, M.M., Brouwer, W.B.F.: Patient and general public preferences for health outcomes: a call to reconsider current guidelines. Soc. Sci. Med. 165, 66–74 (2016)CrossRef

12.

Stolk, E.A., van Nooten, F.E.: Values for resource allocation should expose the adaptation process, not the outcome. Virtual Mentor. 7(2), pii: virtualmentor.2005.7.2.jdsc3-0502 (2005). https://doi.org/10.1001/virtualmentor.2005.7.2.jdsc3-0502

13.

Augestad, L.A., Rand-Hendriksen, K., Stavem, K., Kristiansen, I.S.: Time trade-off and attitudes toward euthanasia: implications of using ‘death’ as an anchor in health state valuation. Qual. Life Res. 22(4), 705–714 (2013)CrossRef

14.

Dolan, P., Gudex, C., Kind, P., Williams, A.: The time trade-off method: results from a general population study. Health Econ. 5(2), 141–154 (1996)CrossRef

15.

Dolan, P.: Effect of age on health state valuations. J Health Serv Res Policy. 5(1), 17–21 (2000)CrossRef

16.

Dolan, P., Roberts, J.: To what extent can we explain time trade-off values from other information about respondents? Soc. Sci. Med. 54(6), 919–929 (2002)CrossRef

17.

Bernert, S., Fernández, A., Haro, J.M., König, H.H., Alonso, J., Vilagut, G., Sevilla-Dedieu, C., de Graaf, R., Matschinger, H., Heider, D., Angermeyer, M.C., ESEMeD/MHEDEA 2000 Investigators: Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries. Value Health 12(5), 750–758 (2009)CrossRef

18.

Van Nooten, F.E., van Exel, N.J., Koolman, X., Brouwer, W.B.: Married with children the influence of significant others in TTO exercises. Health Qual Life Outcomes. 2(13), 94 (2015)CrossRef

19.

Krol, M., Attema, A.E., van Exel, J., Brouwer, W.: Altruistic preferences in time tradeoff: consideration of effects on others in health state valuations. Med. Decis. Mak. 36(2), 187–189 (2016)CrossRef

20.

Bhatnagar, V., Frosch, D.L., Tally, S.R., Hamori, C.J., Lenert, L., Kaplan, R.M.: Evaluation of an internet-based disease trajectory decision tool for prostate cancer screening. Value Health 12(1), 101–108 (2009)CrossRef

21.

van der Pol, M., Shiell, A.: Extrinsic goals and time tradeoff. Med. Decis. Mak. 27(4), 406–413 (2007)CrossRef

22.

Krol, M., Sendi, P., Brouwer, W.: Breaking the silence: exploring the potential effects of explicit instructions on incorporating income and leisure in TTO exercises. Value Health 12(1), 172–180 (2009)CrossRef

23.

Ayalon, L., King-Kallimanis, B.L.: Trading years for perfect health: results from the health and retirement study. J Aging Health. 22(8), 1184–1197 (2010)CrossRef

24.

Dolan, P.: Thinking about it: thoughts about health and valuing QALYs. Health Econ. 20(12), 1407–1416 (2011)CrossRef

25.

Rowen, D., Brazier, J., Young, T., Gaugris, S., Craig, B.M., King, M.T., Velikova, G.: Deriving a preference-based measure for cancer using the EORTC QLQ-C30. Value Health 14(5), 721–731 (2011)CrossRef

26.

Guest, J.F., Sladkevicius, E., Gough, N., Linch, M., Grimer, R.: Utility values for advanced soft tissue sarcoma health states from the general public in the United Kingdom. Sarcoma. 2013, 863056 (2013)PubMedPubMedCentral

27.

Richardson, J., Peacock, S.J., Iezzi, A.: Do quality-adjusted life years take account of lost income? Evidence from an Australian survey. Eur J Health Econ. 10(1), 103–109 (2009)CrossRef

28.

Meltzer, D., Weckerle, C., Chang, L.M.: Do people consider financial effects in answering quality of life questions. Med. Decis. Mak. 19, 517 (1999)CrossRef

29.

Tilling, C., Krol, M., Tsuchiya, A., Brazier, J., van Exel, J., Brouwer, W.: Does the EQ-5D reflect lost earnings? Pharmacoeconomics. 30(1), 47–61 (2012)CrossRef

30.

Izadpanah, A., Sinno, H., Vorstenbosch, J., Lee, B.T., Lin, S.J.: Thigh laxity after massive weight loss: a utilities outcomes assessment. Ann. Plast. Surg. 71(3), 304–307 (2013)CrossRef

31.

van Nooten, F.E., van Exel, N.J., Eriksson, D., Brouwer, W.B.: ``Back to the future’’: influence of beliefs regarding the future on TTO answers. Health Qual. Life Outcomes. 12(14), 4 (2016)CrossRef

32.

Essink-Bot, M.L., Stuifbergen, M.C., Meerding, W.J., Looman, C.W., Bonsel, G.J., VOTE group: Individual differences in the use of the response scale determine valuations of hypothetical health states: an empirical study. BMC Health Serv. Res. 27(7), 62 (2007)CrossRef

33.

Lamers, L.M., Stalmeier, P.F., Krabbe, P.F., Busschbach, J.J.: Inconsistencies in TTO and VAS Values for EQ-5D Health States. Med. Decis. Mak. 26(2), 173–181 (2006)CrossRef

34.

Rutten-van Mölken, M.P., Hoogendoorn, M., Lamers, L.M.: Holistic preferences for 1-year health profiles describing fluctuations in health: the case of chronic obstructive pulmonary disease. Pharmacoeconomics. 27(6), 465–477 (2009)CrossRef

35.

Kirsch, J., McGuire, A.: Establishing health state valuations for disease specific states: an example from heart disease. Health Econ. 9(2), 149–158 (2000)CrossRef

36.

van Nooten, F., Brouwer, W.: The influence of subjective expectations about length and quality of life on time trade-off answers. Health Econ. 13(8), 819–823 (2004)CrossRef

37.

van Nooten, F.E., Koolman, X., Brouwer, W.B.: The influence of subjective life expectancy on health state valuations using a 10 year TTO. Health Econ. 18(5), 549–558 (2009)CrossRef

38.

Johnson, J.A., Luo, N., Shaw, J.W., Kind, P., Coons, S.J.: Valuations of EQ-5D health states: are the United States and United Kingdom different? Med. Care 43(3), 221–228 (2005)CrossRef

39.

Knies, S., Evers, S.M., Candel, M.J., Severens, J.L., Ament, A.J., Knies, S., Evers, S.M., Candel, M.J., Severens, J.L., Ament, A.J.: Utilities of the EQ-5D: transferable or not? Pharmacoeconomics. 27(9), 767–779 (2009)CrossRef

Titel: What should we know about the person behind a TTO?
verfasst von: Floortje van Nooten
Jan Busschbach
Michel van Agthoven
Job van Exel
Werner Brouwer
Publikationsdatum: 18.04.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: The European Journal of Health Economics / Ausgabe 9/2018
Print ISSN: 1618-7598
Elektronische ISSN: 1618-7601
DOI: https://doi.org/10.1007/s10198-018-0975-1

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2018

The economic impact of multiple sclerosis to the patients and their families in Norway

People’s perception and cost-effectiveness of home confinement during an influenza pandemic: evidence from the French case

Impact of increasing treatment rates on cost-effectiveness of subcutaneous immunotherapy (SCIT) in respiratory allergy: a decision analytic modelling approach

Tackling the chronic disease burden: are there co-benefits from climate policy measures?

Some adjustments to the human capital and the friction cost methods

Cost–utility analysis of an intervention designed to reduce the critical handling error of insufficient inspiratory effort